Buy & Sell ResMed Inc. (RMD) – ResMed Inc. Price Today
Aura AI Summary
Key Stats
- $29.99BMarket Cap
- HealthSector
- -21.39%3M Drawdown
- $29.17BEnterprise Value
- 1.16%Dividend Yield
- 62 daysTypical Hold Time
ResMed Inc. (RMD) is currently valued at a market capitalization of $29.99B, with an enterprise value of $29.17B. Over the past 52 weeks, ResMed Inc. has traded between a low of $205.02 and a high of $293.73, highlighting its annual price range. Over the past three months, ResMed Inc. has recorded a drawdown of -21.39%, reflecting recent price volatility. ResMed Inc. offers a dividend yield of 1.16%, with the most recent dividend of $0.60 paid on 12 Feb 26. On average, investors hold ResMed Inc. for approximately 62 days, indicating typical investor behavior on the platform.
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Most Recent News
Uber commits $10B to expand Robotaxi fleet and equity, challenging Tesla and Waymo dominance.
Uber plans to invest $10 billion in its Robotaxi business, allocating $2.5 billion to acquire stakes in Robotaxi companies and $7.5 billion to expand its fleet starting in 2027 with over 100,000 vehicles. The company is partnering with firms like Nur...
Ripple secures 10 major deals in 2026 but none boost XRP token demand directly.
Ripple closed 10 major deals in early 2026 with big names like Deutsche Bank, JPMorgan, and Mastercard, plus expanded fully into Brazil. These partnerships enhance Ripple's payment infrastructure but do not create direct demand for its XRP token, as ...
Cerebras IPO demand surges; Applied Materials eyes strong AI-driven quarter amid inflation and geopolitical risks.
Cerebras Systems leads a busy IPO week with demand pushing its share price range up to $125-$135, potentially raising $3.78B. Applied Materials is expected to report another strong quarter driven by AI infrastructure demand and its $5B EPIC Center in...